Research

Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537134/

Editorial: Emerging Challenges in the Diagnosis and Treatment of Autoimmune Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398345/

Autoimmune seizures and epilepsy February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391086/

The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536844/

Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705619/

Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783555/

GABAA receptor autoimmunity February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501640/

Cerebellar ataxia as a presenting symptom in a patient with anti-NMDA receptor encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624087/